Clinical Improvement of AERD Achieved With Dupilumab Use for Asthma, CRS With Nasal Polyps
May 3rd 2022Patients with aspirin-exacerbated respiratory disease (AERD) who initiated treatment with dupilumab as an add-on asthma or chronic rhinosinusitis with nasal polyps therapy reported rapid clinical improvement that was sustained after 3 months.
Read More
Study Calls for Sex-Specific Tactics to Reduce Rising Heart Attacks in Young Adults
May 3rd 2022These investigators wanted to better understand the reasons for the increased risk for acute myocardial infarctions among young women, who have the largest increase in hospitalization for heart attacks.
Read More
PLWH in Romania Need More Comprehensive Care, Advocate Says
May 3rd 2022Nicoleta Dascalu, founding member and advocacy manager of Asociaţia Română Anti-SIDA (ARAS; Romanian Association Against AIDS), discusses the status of care for persons living with HIV/AIDS (PLWH) in Romania, including health care coverage and lack of adequate medication access.
Watch
European Effort Will Make Cholangiocarcinoma Treatment Info Available in Multiple Languages
May 2nd 2022The project seeks to develop materials explaining chemotherapy regimens for patients with biliary tract cancers and then translate these materials into “standardized, high-quality, free, and easily accessible resources."
Read More
Cardiovascular Risk Significantly Greater in Patients With Psoriatic Disease
May 2nd 2022A significantly greater risk of cardiovascular events was observed among a multiethnic Brazilian population of patients with psoriasis and psoriatic arthritis vs controls, in which those in the sixth decade of life had the highest risk.
Read More
Dr Steven Yeh Explains Xipere Follow-up Findings, Learning Curves for Clinicians
May 2nd 2022Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, discusses the length of Xipere's treatment benefits and potential learning curves regarding its suprachoroidal delivery mechanism.
Watch
The FDA sets a tentative date for a decision on authorizing a COVID-19 vaccine in children under 5 years of age; the American Academy of Pediatrics will review all of its guidance for unproven race-based recommendations contributing to health disparities; the FDA rejects 2 China-tested cancer treatments.
Read More
Poorer Outcomes Associated With Recurrent aGVHD Warrant Independent Recognition, Says Study
May 2nd 2022After a median follow-up of 535 days, analysis showed that recurrent acute graft-versus-host disease (RaGVHD) carried several implications for survival, leading the researchers to call for further risk stratification of aGVHD.
Read More
Study Gives Insight Into Fidaxomicin’s Gut-Sparing Activity in Clostridioides difficile
May 2nd 2022Fidaxomicin, now commonly used to treat Clostridioides difficile infection, selectively targets the bacterium while sparing crucial gut commensals that protect against colonization. However, knowledge gaps in the molecular basis of its narrow-spectrum activity remain.
Read More
RNA Sequencing Identifies Novel, Specific Biomarkers in Pterygia
May 1st 2022While risk factors for pterygia are well-known, the underlying disease mechanisms have not been fully clarified in past studies. A new analysis using RNA sequencing pinpointed ptergyia-specific biomarkers and potential therapeutic targets.
Read More
Hypomethylating Agents With Venetoclax Can Be Effective Bridge to Transplant in AML
May 1st 2022Among a cohort of 88 patients with acute myeloid leukemia who received hypomethylating agents with venetoclax prior to allogeneic hematopoietic cell transplant, 85% had achieved morphologic complete response at 100 days.
Read More
Contributor: Exploring the Patient Experience as a Driver for Loyalty in the Digital Age
May 1st 2022In this contributor piece, Gary Hamilton, CEO of InteliChart, the online patient engagement platform, explores how the digital evolution in health care can lead to quality care, convenience, and ongoing patient loyalty.
Read More
Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer Treatment
April 30th 2022Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.
Read More